...
首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
【24h】

Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC

机译:肿瘤细胞编程死亡配体1在NSCLC中的表达和免疫细胞浸润的预后影响

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Infiltration of T and B/plasma cells has been linked to NSCLC prognosis, but this has not been thoroughly investigated in relation to the expression of programmed death ligand 1 (PD-L1). Here, we determine the association of lymphocytes and PD-L1 with overall survival (OS) in two retrospective cohorts of operated NSCLC patients who were not treated with checkpoint inhibitors targeting the programmed death 1/PD-L1 axis. Moreover, we evaluate how PD-L1 positivity and clinicopathologic factors affect the prognostic association of lymphocytes.
机译:简介:T和B /血浆细胞的渗透与NSCLC预后有关,但这尚未彻底研究程序死亡配体1(PD-L1)的表达。 在这里,我们在两种回顾性的NSCLC患者中,确定淋巴细胞和PD-L1与整体存活(OS)的关联,其操作的NSCLC患者未受瞄准编程死亡1 / PD-L1轴的检查点抑制剂。 此外,我们评估PD-L1积极性和临床病理因素如何影响淋巴细胞的预后关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号